Biological dosimetry and Bayesian analysis of chromosomal damage in thyroid cancer patients

Radiation Protection Dosimetry

Volumn 129, Issue 4, 2008, Pages 372-380

  Serna, Alfredo ^a   Alcaraz, Miguel ^b   Navarro, Jose Luis ^a   Acevedo, Cristina ^a   Vicente, Vicente ^b   Canteras, Manuel ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; BAYES THEOREM; BLOOD SAMPLING; CALCULATION; CHILD; CHROMOSOME ABERRATION; CHROMOSOME DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE; MALE; MICRONUCLEUS TEST; POISSON DISTRIBUTION; RADIATION DOSE DISTRIBUTION; RADIATION EXPOSURE; THYROID CANCER;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; BAYES THEOREM; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CELLS, CULTURED; CHILD; CHROMOSOME ABERRATIONS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHOCYTES; MALE; MIDDLE AGED; RADIOMETRY; RELATIVE BIOLOGICAL EFFECTIVENESS; THYROID NEOPLASMS;

EID: 49249102658     PISSN: 01448420     EISSN: None     Source Type: Journal    
DOI: 10.1093/rpd/ncm444     Document Type: Article

References (49)

1. Benua, R. S., Cicale, N. R., Sonenberg, M. and Rawson, R. W. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am. J. Roentgenol. 87. 171-182 (1962).
2. Van Nostrand, D., Atkins, F., Yeganeh, F., Acio, E., Bursaw, R. and Wartofsky, L. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma. Thyroid 12(2), 121-134 (2002).
3. International Atomic Energy Agency. Cytogenetic analysis for radiation dose assessment. IAEA Technical Report 405 (2001).
4. Leonard, A., Rueff, J., Gerber, G. B. and Leonard, E. D. Usefulness and limits of biological dosimetry based on cytogenetic methods. Radiat. Prot. Dosim. 115, 448-454 (2005).
5. Bonassi, S., Fenech, M., Lando, C., Ling, Y., Ceppi, M., Chang, W. P., Holland, N., Kirsch-Volders, M., Zeiger, E. and Ban, S. et al. Human micronuleus project: International database comparison for results with the cytokinesis-block micronucleus assay in human lymphocites: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronucleus. Environ. Mol. Mutagen, 37, 31-45 (2001).
6. Edwards, A. A., Lloyd, D. C. and Purrot, R. J. Radiation induced chromosome aberrations and the Poisson distribution. Radiat. Environ. Biophys. 16(2), 89-100 (1979).
7. Laederman, J. P., Valley, J. F. and Bochud, F. O. Measurement of radiactive simples: Applications of Bayesian statistical decision theory Metrologia 42, 442-448 (2005).
8. Loredo, T. J. The Promise of Bayesian Inference for Astrophysics Statistical Challenges in Modern Astronomy (New York: Springer-Verlag), pp. 257-297 (1992).
9. D'Agostini, G. Bayesian inference in processing experimental data: principles and basic applications. Rep. Prog. Phys. 66(9), 1383-1419 (2003).
10. Raeside, D. E. Bayesian statistics: A guided tour. Med. Phys. 3(1), 1-11 (1976).
11. Groer, P. G. Exact and approximate Bayesian estimation of net counting rates. Radiat. Prot. Dosim. 102, 265-268 (2002).
12. Little, T. T., Miller, G. and Guilmette, R. Internal dosimetry of uranium isotopes using Bayesian inference methods. Radiat. Prot. Dosim. 105, 413-416 (2003).
13. Voisin, P., Roy, L., Hone, P. A., Edwards, A. A., Lloyd, D. C., Stephan, G., Romm, H., Groer, P. G. and Brame, R. Criticality accident dosimetry by chromosomal analysis. Radiat. Prot. Dosim. 110, 443-447 (2004).
14. Brahme, R. S. and Groer, P. G. Bayesian analysis of overdispersed chromosome aberration data with the negative binomial model. Radiat. Prot. Dosim. 102(2), 115-119 (2003).
15. Lea, D. E. and Catcheside, D. G. The mechanism of the induction by radiation of chromosome aberrations in Tradescantia. J. Genet. 44 216-245 (1942).
16. Dale, R. G. The application of the linear-quadratic function to fractionated and protracted radiotherapy. Br J. Radiol. 58, 515-528 (1985).
17. Brenner, D. J., Hlatky, L. R., Hanhfeldt, P. J., Huang, Y. and Sachs, R. K. The linear-quadratic model and most of other common radiobiological models result in similar predictions of time-dose relalionships. Radiat. Res. 150, 83-91 (1998).
18. Sachs, R. K., Hahnfeld, P. and Brenner, D. J. The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair. Int. J. Radiat. Biol. 72(4), 351-374 (1997).
19. Watanabe, N., Yokoyama, K. and Kimuya, S. Radiosensitivity after iodine-131 therapy for thyroid cancer using the micronucleus assay. J. Nucl. Med. 39, 436-444 (1998).
20. 131I therapy of thyroid cancer: Assessment by micronucleus assay of lymphocytes. J. Nucl. Med. 45(4), 608-611 (2004).
21. Fenech, M. and Morley, A. A. Cytokinesis block micronucleus method in human lymphocytes: Effect of in vivo ageing and low dose X-irradiation Mutat. Res. 161, 193-298 (1986).
22. Kellerer, A. M. and Rossi, H. H. The theory of dual radiation action Curr. Top. Radiat. Res. Q. 8, 85-158 (1972).
23. Merkle, W. Statistical methods in regression and calibration analysis of chromosome aberration data. Radiat. Environ. Biophys. 21, 217-233 (1983).
24. Frome, E. L., Kutner, M. H. and Beauchamp, J. J. Regression analysis of Poisson-distributed data. J. Am. Stat. Assoc. 58, 935-940 (1973).
25. Jeffreys, H. Theory of Probability. (Clarendon: Oxford) (1961).
26. Narsky, I. Estimation of upper limits using Poisson statistics. Nucl. Instr. Meth. Phys. Res. A. 450(2), 444-455 (2000).
27. Villegas, C. On the representation of ignorance. J. Am. Stat. Assoc. 72(359), 651-654 (1977).
28. Papworth, D. Curve fitting ky maximum likelihood. Appendix to paper by J.R.K Savage, radiation induced chromosomal aberrations in the plant Trasdescantia. Dose-response curves. Radiat. Botanics 15, 87 (1975).
29. Merkle, W. Poisson goodness-of-fit for radiation-induced chromosome aberrations. Int. J. Radiat. Biol. 40(6), 685-692 (1981).
30. North, D. L., Shearer, D. R., Hennesey, J. V. and Donovan, G. L. Effective half life of 13II in thyroid cancer patients. Health Phys. 81(3), 325-329 (2001).
31. eff) for patients with thyroid cancer. Health Phys. 91(2), 119-122 (2006).
32. Venencia, C. D., Germanier, A. G., Bustor, S. R., Giovannini, A. A. and Wyse, E. P. Hospital discharge of patients with thyroid carcinoma treated with 13II. J. Nucl. Med. 43(1), 61-65 (2002).
33. Luster, M., Sherman, S. I., Skarulis, M. C., Reynolds, J. R., Lassman, M., Haenscheid, H. and Reigers, C. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormona and after thyroid hormona withdrawal in thyroid carcinoma. Eur. J. Nucl. Med. Mol. Imaging 30(10), 1371-1377 (2003).
34. Bhat, N. N. and Rao, B. S. Dose rate effect on micronuclei induction in cytokinesis blocked human peripheral blood lymphocytes. Radiat. Prot. Dosim. 106(1), 45-52 (2003).
35. Lloyd, D. C., Edwards, A. A., Prosser, J. S. and Corp, M. J. The dose-response relationship obtained at constant irradiation times for the induction of chromosome aberrations in human lymphocytes by cobalt-60 gamma rays. Radiat. Environ. Biophys. 23, 179-189 (1984).
36. Schmid, W. The micronucleus test. Mutat. Res. 31, 9-15 (1975).
37. Castillo, J., Benavente-Garcia, J., Lorente, J., Alcaraz, M., Redondo, A., Ortuño, A. and Del Rio, J. A. Antioxidant activity and radioprotective effects against chromosomal damage induced in vivo by X-rays of flavan-3-ols (Procyanidins) front grape seeds (Vitis vinifera): Comparative study versus other phenolic and organic compounds J. Agric. Food Chem. 4, 1730-1745 (2000).
38. Del Baño, M. J., Castillo, J., Benavente-García, O., Lorente, J., Martín-Gil, R., Acevedo, C. and Alcaraz, M. Radioprotective effects against to chromosomal damage induced in human lymphocytes by γ-rays of Rosemary phenolics: Carnosic acid, carnosol and rosmarinic Acid. J. Agric. Food Chem. 54, 2064-2068 (2006).
39. Benavente-García, O., Castillo, J., Lorente, J. and Alcaraz, M. Radioprotective effects in vivo of phenolics extracted from Olea europaea L. leaves against X-ray induced chromosomal damage: Comparative study versus several flavonoids and sulfur-containing compounds. J. Med. Food 5(3), 123-133 (2002).
40. Castillo, J., Benavente-Garcia, J., Del Baño, J. M., Lorente, J., Alcaraz, M. and Dato, M. J. Radioprotective effects against to chromosomal damage induced in human lymphocytes by X-rays as a function of polymerisation grade of grape seed extracts. J. Med. Food 4 (2), 117-123 (2001).
41. Alcaraz, M., Chico, P., Saura, A., Armero, D. and Vicente, V. Radioprotective effects of flavonoids against to chromosomal damage: relation between the structure and activity. In: XI International Congress of The International Radiation Protection Association, Madrid (1a1), 20, 2004.
42. Alcaraz, M., Navarro, J. L., Acevedo, C., Vicente, V. and Canteras, M. Genotoxic effects of ionising radiation used in diffierent radiologogy and nuclear medicine procedures. In: XI International Congress of The International Radiation Protection Association. Madrid (1C1), 34, 2004.
43. Lloyd, D. C. and Edwards, A. A. Chromosome aberrations in human lymphocytes. Effect of radiation quality, dose and dose rate. In: Radiation Induced Chromosome Damage in Man, Ishihara, T. and Sasaki, M. S., Eds. (New York) pp. 23-49 (1983.)
44. Müller, W. U. and Rode, A. The micronucleus assay in human lymphocytes after high radiation doses (5-15 Gy). Mutat. Res. 502 47-51 (2002).
45. Monsieurs, M. A., Thierens, H. M., Vral, A., Bras, B., De Ridder, L. and Dierckx, R. A. Patient dosimetry after 13II-MIBG therapy for neuroblastoma and carcinoid tumours. Nucl. Med. Commun. 22, 367-374 (2001).
46. Monsieurs, M. A., Thierens, H. M., Vral, A. M. and van de Wiele, Ch. Adaptive response in patients treated with 131-I. J. Nucl. Med. 41 (1), 17-22 (2000).
47. M'Kacher, R., Legal, J. D., Schlumberger, M., Voisin, P., Aubert, B., Gaillard, N. and Parmentier, C. Biological dosimetry in patients treated with iodine-131 for difftrentiated thyroid carcinoma. J. Nucl. Med. 37, 1860-1864 (1996).
48. De Keizer, B., Hoekstra, A. and Konijnenberg, M. W. Bone marrow dosimetry and safety of high 13II activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer. J. Nucl. Med. 45, 1549-1554 (2004).
49. Haenscheid, H., Lassmann, M., Luster, M., Thomas, S. R., Pacini, F., Ceccarelli, C., Ladenson, P. W., Wahl, R. L., Schlumberger, M., and Ricard, M. et al., Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer. procedures and results of a prospective international controlled study of ablation afier rhTSH or hormone withdrawal. J. Nucl. Med. 47, 648-654 (2006).